SCHEMBL26075661

SCHEMBL26075661

Cc1ccc2nc(-c3ccc(-c4ccc(N(C)C)cc4)cn3)cc(C(=O)O)c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.56
▸ KDM4E B2RXH2 4/20 0.56
▸ HSD17B10 Q99714 3/20 0.56
▸ DHODH Q02127 4/20 0.50
▸ TP53 P04637 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ HIF1A Q16665 2/20 0.45
▸ PTGES O14684 1/20 0.45
▸ ALOX5 P09917 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ CASP7 P55210 1/20 0.45
▸ MAPT P10636 5/20 0.45
▸ PDE10A Q9Y233 1/20 0.43
▸ MAPK1 P28482 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ EIF4A1 P60842 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23590114 0.89 DHODH (0.60) ALDH1A1KDM4EHSD17B10DHODHHIF1A
SCHEMBL26074576 0.88 EIF4A1 (0.46) ALDH1A1KDM4EHSD17B10DHODHTP53
SCHEMBL26074468 0.85 MAPT (0.62) ALDH1A1KDM4EHSD17B10DHODHTP53
SCHEMBL23590037 0.85 DHODH (0.45) ALDH1A1HSD17B10DHODHHIF1APTGES
SCHEMBL26075662 0.84 ALDH1A1 (0.56) ALDH1A1KDM4EHSD17B10DHODHTP53
SCHEMBL26075654 0.82 KDM4E (0.53) ALDH1A1KDM4EHSD17B10DHODHTP53
SCHEMBL23590252 0.78 DHODH (0.74) ALDH1A1KDM4EHSD17B10DHODHTP53
SCHEMBL23590222 0.74 PLA2G2A (0.67) ALDH1A1KDM4EHSD17B10DHODHLMNA
SCHEMBL23590113 0.73 DHODH (0.60) ALDH1A1KDM4EHSD17B10DHODHTP53
SCHEMBL23590223 0.73 KDM4E (0.68) ALDH1A1KDM4EHSD17B10DHODHTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD ALDH1A1 88/4885KDM4E 1396/4885HSD17B10 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback